CN Patent

CN109106696A — 吡仑帕奈口溶膜剂及其制备方法

Assigned to Taiyangsheng Bozhou Biomedical Technology Co ltd · Expires 2019-01-01 · 7y expired

What this patent protects

本发明公开了一种吡仑帕奈口溶膜剂及其制备方法，属于药物制剂领域，能够解决现有吡仑帕奈药物剂型服用不便的问题。所述吡仑帕奈口溶膜剂包括粒径(D90)小于35μm的吡仑帕奈粒子、成膜剂和崩解剂。所述吡仑帕奈口溶膜剂可用于治疗癫痫。

USPTO Abstract

本发明公开了一种吡仑帕奈口溶膜剂及其制备方法，属于药物制剂领域，能够解决现有吡仑帕奈药物剂型服用不便的问题。所述吡仑帕奈口溶膜剂包括粒径(D90)小于35μm的吡仑帕奈粒子、成膜剂和崩解剂。所述吡仑帕奈口溶膜剂可用于治疗癫痫。

Drugs covered by this patent

Patent Metadata

Patent number
CN109106696A
Jurisdiction
CN
Classification
—
Expires
2019-01-01
Drug substance claim
No
Drug product claim
No
Assignee
Taiyangsheng Bozhou Biomedical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.